Citius Pharmaceuticals (CTXR) EPS (Basic) (2010 - 2026)
Citius Pharmaceuticals' (CTXR) quarterly EPS (Basic) came in at -$0.95 in Q1 2026, up 25.42% YoY from -$0.76 in Q1 2025, and down 148.09% on a QoQ basis from -$0.38 in Q4 2025.
Citius Pharmaceuticals (CTXR) EPS (Basic) (2010 - 2026) Analysis & Trends
Citius Pharmaceuticals (CTXR) has 17 years of EPS (Basic) data on file, last reported at -$0.95 in Q1 2026.
- Quarterly EPS (Basic) rose 25.42% year-over-year to -$0.95 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.06 (up 58.89% YoY) and the FY2025 annual result came in at -$3.38, up 43.37% from the prior year.
- EPS (Basic) declined to -$0.95 in Q1 2026, from -$0.38 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.38 in Q4 2025 to a low of -$1.83 in Q3 2023.
- A 5-year average of -$1.25 and a median of -$1.34 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) tumbled 136.28% — and 2025, when it soared 70.67%.
- Tracing CTXR's EPS (Basic) over 5 years: stood at -$0.61 in 2022, then plunged by 136.28% to -$1.45 in 2023, then gained by 10.2% to -$1.3 in 2024, then soared by 70.67% to -$0.38 in 2025, then plunged by 148.09% to -$0.95 in 2026.
- The last three EPS (Basic) figures came in at -$0.95 (Q1 2026), -$0.38 (Q4 2025), and -$0.72 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Citius Pharmaceuticals | 15.71 Mn | 15.71 Mn | 1.00 Mn | -0.34 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.95 |
| Dec 31, 2025 | -0.38 |
| Sep 30, 2025 | -0.72 |
| Jun 30, 2025 | -0.80 |
| Mar 31, 2025 | -1.27 |
| Dec 31, 2024 | -1.30 |
| Sep 30, 2024 | -1.71 |
| Jun 30, 2024 | -1.57 |
| Mar 31, 2024 | -1.34 |
| Dec 31, 2023 | -1.45 |
| Sep 30, 2023 | -1.83 |
| Jun 30, 2023 | -1.38 |
| Mar 31, 2023 | -1.80 |
| Dec 31, 2022 | -0.61 |
| Sep 30, 2022 | -1.37 |
| Jun 30, 2022 | -1.52 |
| Mar 31, 2022 | -1.29 |
| Dec 31, 2021 | -1.58 |
| Sep 30, 2021 | -1.14 |
| Jun 30, 2021 | -1.33 |